Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cancer Research

• Publication date

  2010-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-10-2638PMID 21159654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [OCT4 expression in hepatocellular carcinoma and its clinical significance].

  2010cited by this paper
• MafA promotes the reprogramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin+ cells

  2010cited by this paper
• Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis

  2010cited by this paper
• Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

  2010cited by this paper
• SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas

  2009cited by this paper
• Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.

  2009cited by this paper
• EMT: when epithelial cells decide to become mesenchymal-like cells.

  2009cited by this paper
• p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

  2009cited by this paper
• An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma

  2009cited by this paper
• MAD2B, a Novel TCF4-binding Protein, Modulates TCF4-mediated Epithelial-Mesenchymal Transdifferentiation*

  2009cited by this paper
• Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.

  2009cited by this paper
• Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer.

  2008cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells

  2008cited by this paper
• Module map of stem cell genes guides creation of epithelial cancer stem cells.

  2008cited by this paper
• Identification and expansion of the tumorigenic lung cancer stem cell population

  2008cited by this paper
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

  2008cited by this paper
• Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Cancer Stem Cells

  2007cited by this paper
• Lung cancer: Future directions

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• Cancer stem cells.

  2006cited by this paper
• Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro.

  2006cited by this paper
• Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

  2005cited by this paper
• Developmental cell biology: Regulatory networks in embryo-derived pluripotent stem cells

  2005cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• Multidisciplinary management of lung cancer.

  2004cited by this paper
• The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.

  2003cited by this paper
• Oct-3/4 is a dose-dependent oncogenic fate determinant.

  2003cited by this paper
• Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.

  2003cited by this paper
• Human embryonic genes re-expressed in cancer cells

  2001cited by this paper
• Examination of POU homeobox gene expression in human breast cancer cells

  1999cited by this paper
• Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation.

  1998cited by this paper
• Orchestra

  1998cited by this paper
• Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4.

  1998cited by this paper

• Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation.

  2026cites this paper
• Impact of piR_004530 reactivation in lung cancer: implications for recurrence and survival of lung squamous cell carcinoma patients

  2025cites this paper
• Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor differentiation and therapy.

  2025cites this paper
• Bromodomain-Driven Regulation of Stem Cells: A Potential Target for Cancer Therapeutic Intervention

  2025cites this paper
• Role of OCT-4 and NANOG in the Malignant Transformation of Oral Submucous Fibrosis: An Immunohistochemical Evaluation

  2025cites this paper
• β-catenin/TCF4/NANOG axis controls miR-302 transcription in colorectal cancer cells.

  2025cites this paper
• OCT4-mediated upregulation of DUSP6 promotes metastasis in non-small-cell lung cancer

  2025cites this paper
• Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer

  2025cites this paper
• Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance

  2025cites this paper
• Integrated multi-optosis model for pan-cancer candidate biomarker and therapy target discovery

  2025cites this paper
• DNMT1 inhibition by synergistic application of curcumin and 5-AZA-2′-deoxycytidine implicates enhanced therapeutic potential against lung adenocarcinoma

  2025cites this paper
• SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC

  2025cites this paper
• Differentiation Treatment Applied to Lung Cancer Model Reduces Pathogenic Traits in Vitro

  2025cites this paper
• Disruption of NANOG-driven epithelial-mesenchymal transition (EMT) and self-renewal restores drug sensitivity in colorectal cancer.

  2025cites this paper
• Gene regulatory network transitions reveal the central transcription factors in lung adenocarcinoma progression

  2025cites this paper
• Interconversion of Cancer Cells and Induced Pluripotent Stem Cells

  2024cites this paper
• Epigenetic control of cell signalling in cancer stem cells.

  2024cites this paper
• Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p

  2024cites this paper
• Exploring the reciprocity between pioneer factors and development.

  2024cites this paper
• Comprehensive Review on the Effect of Stem Cells in Cancer Progression

  2024cites this paper
• Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells

  2024cites this paper
• Depletion of NUAK2 blocks the stemness and angiogenesis and facilitates senescence of lung adenocarcinoma cells via enhancing ferroptosis

  2024cites this paper
• Generation of 3D melanoma models using an assembloid-based approach.

  2024cites this paper
• Mechanisms governing lineage plasticity and metabolic reprogramming in cancer.

  2024cites this paper
• Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor

  2024cites this paper
• The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells

  2024cites this paper
• Long-term maintenance of human endometrial epithelial organoids and their stem cell properties.

  2023cites this paper
• Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy

  2023cites this paper
• Effects of growth factor deprivation on MKN-45 spheroid cells

  2023cites this paper
• POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6

  2023cites this paper
• Evaluating The Impact of Mindfulness Service on Air Travel Experience and Satisfaction: A Mediation and Moderation Model

  2023cites this paper
• Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

  2023cites this paper
• Early stage evaluation of cancer stem cells using platinum nanoparticles/CD_133^+ enhanced nanobiocomposite

  2023cites this paper
• Re-Sensitizing Cancer Stem Cells to Conventional Chemotherapy Agents

  2023cites this paper
• Effect of 5-o-(n-boc-l-alanine)-renieramycin t in the suppression of lung cancer stem cells

  2023cites this paper
• Molecular Mechanisms of Tumor Cell Stemness Modulation during Formation of Spheroids

  2023cites this paper
• Photobiomodulation of A549 Lung Cancer & MRC5 Healthy Lung Cell Lines via 660nm and 808nm Laser Irradiations

  2023cites this paper
• lncRNA GMDS-AS1 restrains lung adenocarcinoma progression via recruiting TAF15 protein to stabilize SIRT1 mRNA.

  2023cites this paper
• Simplified Synthesis of Renieramycin T Derivatives to Target Cancer Stem Cells via β-Catenin Proteasomal Degradation in Human Lung Cancer

  2023cites this paper
• Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells

  2023cites this paper
• Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation.

  2023cites this paper
• Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness

  2023cites this paper
• The Potential of Stem Cells in Treating Breast Cancer.

  2023cites this paper
• Heparanase regulates EMT and cancer stem cell properties in prostate tumors

  2022cites this paper
• FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance

  2022cites this paper
• Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition.

  2022cites this paper
• Cancer stem cells in esophageal squamous cell carcinoma.

  2022cites this paper
• Aptamer-based therapy for targeting key mediators of cancer metastasis (Review)

  2022cites this paper
• KRAB-ZFPs and cancer stem cells identity

  2022cites this paper
• Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs

  2022cites this paper
• Genome-Wide CRISPR Screen Identifies Puf60 as a Novel Stemness Gene of Mouse Embryonic Stem Cells

  2022cites this paper
• Nanog, as a key cancer stem cell marker in tumor progression.

  2022cites this paper
• Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment

  2022cites this paper
• Inhibition of NF-κB signalling reduces the stemness characteristics of lung cancer stem cells

  2022cites this paper
• Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression

  2022cites this paper
• α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer

  2022cites this paper
• 3D and organoid culture in research: physiology, hereditary genetic diseases and cancer

  2022cites this paper
• Enrichment of cancer stem-like cells by controlling oxygen, glucose and fluid shear stress in a microfluidic spheroid culture device

  2022cites this paper
• The Mechanism of Propofol on Non-Small Cell Lung Cancer (NSCLC) through Modulating Mesenchymal Transition (EMT)

  2022cites this paper
• Oct4 facilitates chondrogenic differentiation of mesenchymal stem cells by mediating CIP2A expression

  2022cites this paper
• Magnetic exposure using Samarium Cobalt (SmCO5) increased proliferation and stemness of human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)

  2022cites this paper
• HOPX: A Unique Homeodomain Protein in Development and Tumor Suppression

  2022cites this paper
• The roles of Linc-ROR in the regulation of cancer stem cells

  2022cites this paper
• Targeting EGFR and Monitoring Tumorigenesis of Human Lung Cancer Cells In Vitro and In Vivo Using Nanodiamond-Conjugated Specific EGFR Antibody

  2022cites this paper
• HIF1α/HIF2α induces glioma cell dedifferentiation into cancer stem cells through Sox2 under hypoxic conditions

  2022cites this paper
• Epigenetics alternation in lung fibrosis and lung cancer

  2022cites this paper
• Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.

  2022cites this paper
• Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration.

  2022cites this paper
• Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation

  2022cites this paper
• Evodiamine exerts inhibitory roles in non‑small cell lung cancer cell A549 and its sub‑population of stem‑like cells

  2022influential citation
• Pleiotropic effects of DCLK1 in cancer and cancer stem cells

  2022cites this paper
• Vitamin D affects the Warburg effect and stemness maintenance of non-small-cell lung cancer cells by regulating PI3K/AKT/mTOR signaling pathway.

  2021cites this paper
• Epigenetic Mechanism of Enrichment of A549 Lung Cancer Stem Cells with 5-Fu

  2021cites this paper
• NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.

  2021cites this paper
• Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells

  2021cites this paper
• Persistent effects of pair bonding in lung cancer cell growth in monogamous Peromyscus californicus

  2021cites this paper
• Role of Hexosamine Biosynthetic Pathway on Cancer Stem Cells: Connecting Nutrient Sensing to Cancer Cell Plasticity

  2021cites this paper
• Effects of radiation dose on the stemness-related genes expression in colorectal cancer cell line

  2021cites this paper
• R EVIEW 3D chromatin architecture and epigenetic regulation in cancer stem cells

  2021cites this paper
• Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer.

  2021cites this paper
• 干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用

  2021cites this paper
• The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers

  2021cites this paper
• The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance

  2021cites this paper
• Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines

  2021cites this paper
• HIF1α/HIF2α–Sox2/Klf4 promotes the malignant progression of glioblastoma via the EGFR–PI3K/AKT signalling pathway with positive feedback under hypoxia

  2021cites this paper
• Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer

  2021cites this paper
• Bioinformatics analysis of miRNAs identifies enrichment of axon guidance pathway genes in ovarian cancer stem cells

  2021cites this paper
• Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation

  2021influential citation
• PM2.5 induces the distant metastasis of lung adenocarcinoma via promoting the stem cell properties of cancer cells.

  2021cites this paper
• Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness through the Production of Leukemia Inhibitory Factor

  2021influential citation
• Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

  2021cites this paper
• 3D chromatin architecture and epigenetic regulation in cancer stem cells

  2021cites this paper
• Pluripotency Stemness and Cancer: More Questions than Answers.

  2021cites this paper
• Crenolanib Regulates ERK and AKT/mTOR Signaling Pathways in RAS/BRAF-Mutated Colorectal Cancer Cells and Organoids

  2021influential citation
• Activation of a Ductal-to-Endocrine Transdifferentiation Transcriptional Program in the Pancreatic Cancer Cell Line PANC-1 Is Controlled by RAC1 and RAC1b through Antagonistic Regulation of Stemness Factors

  2021cites this paper
• Cell Populations Expressing Stemness-Associated Markers in Lung Adenocarcinoma

  2021cites this paper
• Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells

  2021cites this paper
• The expression of Oct3/4A mRNA and not its isoforms is upregulated by the HPV16 E7 oncoprotein

  2021cites this paper
• The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway

  2021cites this paper
• Stem cell markers expression evaluation in Oral Squamous Cell Carcinoma

  2021cites this paper